About

Dr. Emily Ko is a leading gynecologic oncologist whose research has fundamentally shaped the modern surgical management of gynecologic cancers, particularly through the adoption and optimization of minimally invasive techniques. Her landmark 2008 study comparing robotic versus open radical hysterectomy (130 citations) provided early, critical evidence supporting the safety and efficacy of robotic surgery, helping to drive a paradigm shift in the field. She further advanced patient care by demonstrating the oncologic validity of robotic-assisted staging for endometrial carcinoma, with her work showing favorable recurrence-free and 5-year survival outcomes (67 citations). Beyond surgical outcomes, Dr. Ko has been a pioneer in surgeon wellness, authoring a highly influential 2012 study (121 citations) that exposed the significant physical strain and urgent need for ergonomic training among gynecologic oncologists performing minimally invasive surgery—a call to action that has spurred institutional changes. Her more recent analyses of the National Cancer Database and development of alternative payment models (ECAP) continue to shape policy and cost-effective care. With over 330 total citations, Dr. Ko’s work bridges technical innovation, surgeon health, and health economics, establishing her as a transformative voice in gynecologic oncology.

Research Focus

Key Achievements

5
H-Index
5
Papers
334
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus open radical hysterectomy: A comparative study at a single institution
130 citations · 2008
📈 Most Prolific Year: 2012 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: University of North Carolina at Chapel Hill, University of Pennsylvania, California University of Pennsylvania

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago